These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
4. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients. Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338 [TBL] [Abstract][Full Text] [Related]
5. De novo inflammatory bowel disease after pediatric orthotopic liver transplant: a case report. Dehghani SM; Eshraghian A; Bahador A; Kakaei F; Geramizadeh B; Malek-Hosseini SA Exp Clin Transplant; 2009 Sep; 7(3):145-8. PubMed ID: 19715523 [TBL] [Abstract][Full Text] [Related]
6. Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Maes BD; Dalle I; Geboes K; Oellerich M; Armstrong VW; Evenepoel P; Geypens B; Kuypers D; Shipkova M; Geboes K; Vanrenterghem YF Transplantation; 2003 Mar; 75(5):665-72. PubMed ID: 12640307 [TBL] [Abstract][Full Text] [Related]
7. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection. Boratyńska M; Banasik M; Patrzałek D; Klinger M Ann Transplant; 2006; 11(2):51-6. PubMed ID: 17494290 [TBL] [Abstract][Full Text] [Related]
8. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients. Asberg A; Midtvedt K; Line PD; Narverud J; Holdaas H; Jenssen T; Reisaeter AV; Johnsen LF; Fauchald P; Hartmann A Transplantation; 2006 Jul; 82(1):62-8. PubMed ID: 16861943 [TBL] [Abstract][Full Text] [Related]
9. The transmission of donor-derived malignant melanoma to a renal allograft recipient. Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479 [TBL] [Abstract][Full Text] [Related]
10. [De novo hemolytic uremic syndrome in a kidney-pancreas recipient in the postoperative period]. Gutiérrez de la Fuente C; Sola E; Alférez MJ; Navarro A; Cabello M; Burgos D; González Molina M Nefrologia; 2004; 24 Suppl 3():3-6. PubMed ID: 15219059 [TBL] [Abstract][Full Text] [Related]
13. Crohn's-like changes in the colon due to mycophenolate? Dalle IJ; Maes BD; Geboes KP; Lemahieu W; Geboes K Colorectal Dis; 2005 Jan; 7(1):27-34. PubMed ID: 15606581 [TBL] [Abstract][Full Text] [Related]
14. Late developing C4d-positive humoral renal allograft rejection associated with withdrawal of mycophenolate mofetil. Sun Q; Tang Z; Chen J; Chen H; Liu Z; Li L Transplant Proc; 2005 Dec; 37(10):4244-5. PubMed ID: 16387089 [TBL] [Abstract][Full Text] [Related]
15. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient. Montini G; Murer L; Ghio L; Pietrobon B; Ginevri F; Ferraresso M; Cardillo M; Scalamogna M; Perfumo F; Edefonti A; Zanon GF; Zacchello G Transpl Int; 2005 Jan; 18(1):36-42. PubMed ID: 15612981 [TBL] [Abstract][Full Text] [Related]
16. Does mycophenolate mofetil increase the incidence of infections in stable renal transplant recipients initially treated with a two-drug regimen? Chen Y; Chu SH; Wei TY; Yen TH; Chiang YJ; Wu CT; Chen HW Transplant Proc; 2004 Sep; 36(7):2122-3. PubMed ID: 15518769 [TBL] [Abstract][Full Text] [Related]
17. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis. Zucker MJ; Baran DA; Arroyo LH; Goldstein DJ; Neacy C; Mele L; Weinberg AD; Prendergast TW; Ribner HS Transplant Proc; 2005 Jun; 37(5):2231-9. PubMed ID: 15964386 [TBL] [Abstract][Full Text] [Related]
18. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60. Xenos EX; Ciancio G; Burke GW; Roth D; Miller J Clin Transplant; 1997 Oct; 11(5 Pt 2):497-9. PubMed ID: 9361949 [TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil-induced colitis in children. Phatak UP; Seo-Mayer P; Jain D; Selbst M; Husain S; Pashankar DS J Clin Gastroenterol; 2009; 43(10):967-9. PubMed ID: 19609219 [TBL] [Abstract][Full Text] [Related]
20. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. Pascual J; van Hooff JP; Salmela K; Lang P; Rigotti P; Budde K Transplantation; 2006 Jul; 82(1):55-61. PubMed ID: 16861942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]